Francesco Calzaferri
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Targeting DNA Methylation: New Paradigms and the Advent of Gene-Selective Tools.
Journal: Chemical research in toxicology
Published: July 10, 2026
Advances in nanomedicine: from design and formulation to regenerative application and theranostics.
Journal: Nanoscale
Published: December 24, 2025
Toward clinical translation of carbon nanomaterials in anticancer drug delivery: the need for standardisation.
Journal: Beilstein journal of nanotechnology
Published: June 18, 2025
Rational Design and Synthesis of Highly Stable Haloflavanone DNA Methyltransferase Inhibitors Inducing Tumor Suppressor Gene Re-expression in Cancer Cells.
Journal: Journal of medicinal chemistry
Published: May 26, 2025
Pharmacological evaluation of non-nucleotide purine derivatives as P2X7 antagonists for the treatment of neuroinflammation in traumatic brain injury.
Journal: British journal of pharmacology
Published: September 25, 2024
3-Halo-3-nitro-aza/thioflavanones: DNMT inhibitors with a two-site binding mode in the hDNMT3A catalytic pocket.
Journal: Bioorganic & medicinal chemistry
Published: July 26, 2024
Retinal response to systemic inflammation differs between sexes and neurons.
Journal: Frontiers in immunology
Published: November 17, 2023
Dual Role of the P2X7 Receptor in Dendritic Outgrowth during Physiological and Pathological Brain Development.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: April 22, 2022
Novel Purine Derivative ITH15004 Facilitates Exocytosis through a Mitochondrial Calcium-Mediated Mechanism.
Journal: International journal of molecular sciences
Published: December 06, 2021
Increased expression of the ATP-gated P2X7 receptor reduces responsiveness to anti-convulsants during status epilepticus in mice.
Journal: British journal of pharmacology
Published: August 28, 2021
Synthesis and Pharmacological Evaluation of Novel Non-nucleotide Purine Derivatives as P2X7 Antagonists for the Treatment of Neuroinflammation.
Journal: Journal of medicinal chemistry
Published: February 09, 2021
P2X7 Receptor Antagonism as a Potential Therapy in Amyotrophic Lateral Sclerosis.
Journal: Frontiers in molecular neuroscience
Published: March 25, 2020
Last Updated: 09/26/2026